Core Laboratories (CLB) Misses Q3 EPS by 4c, Guidance Comes in Light

Core Laboratories (NYSE: CLB) reported Q3 EPS of $0.35, $0.04 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $143.5 million versus the consensus estimate of $146.23 million.

GUIDANCE:

Core Laboratories sees Q4 2016 EPS of $0.38-$0.40, versus the consensus of $0.41. Core Laboratories sees Q4 2016 revenue of $143-145 million, versus the consensus of $148.2 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance